Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America-Reference-Cited by-同舟云学术

Active tuberculosis in inflammatory bowel disease patients under treatment from an endemic area in Latin America

Published:2020-11-28 Issue:44 Volume:26 Page:6993-7004
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:WJG

Author:

Fortes Flora Maria Lorenzo,Sorte Ney Boa,Mariano Victor D,Andrade Laíla D,Oliveira Fernanda A,Santos Monique CA,Santos Cláudia Ivanilda N dos,Passos Catharina A,Pacheco Mila P,Surlo Valdiana C,Almeida Neogélia P de,Fontes Jaciane AM,Pimentel Andréa M,Rocha Raquel,Santana Genoile Oliveira

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference34 articles.

1. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

2. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review

3. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil

4. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy?

5. Antitumor Necrosis Factor Therapy for Inflammatory Bowel Disease: A Review of Agents, Pharmacology, Clinical Results, and Safety

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous and paraspinal tuberculous abscesses in a patient with Crohn’s disease;BMJ Case Reports;2024-08

2. Challenges in the diagnosis and treatment of inflammatory bowel disease in Latin America;The Lancet Gastroenterology & Hepatology;2024-03

3. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study;Gastroenterología y Hepatología;2024-01

4. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study;Gastroenterología y Hepatología (English Edition);2024-01

5. Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients;World Journal of Gastroenterology;2023-03-07